Thymic Stromal Lymphopoietin Receptor Molecules And Uses Thereof

Abstract

The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 18, 2005
  • Application: Jun 28, 2001
    US US 89559301 A
  • Priority: Jun 28, 2001
    US US 89559301 A
  • Priority: Jun 28, 2000
    US US 21465800 P

Download Citation


Sign in to the Lens

Feedback